Relationship of opioid prescription sales and overdoses, North Carolina

Drug and Alcohol Dependence

Volumn 132, Issue 1-2, 2013, Pages 81-86

  Modarai, F ^a   Mack, K ^a   Hicks, P ^b   Benoit, S ^b   Park, S ^b,e   Jones, C ^a   Proescholdbell, S ^c   Ising, A ^d   Paulozzi, L ^a  

^a NATIONAL CENTER FOR INJURY PREVENTION AND CONTROL   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c Injury and Violence Prevention Unit   (United States)

^d UNIVERSITY OF NORTH CAROLINA   (United States)

^e McKing Consulting Corporation   (United States)

Author keywords

Drug; North Carolina; Opiates; Opiods; Overdoses; Prescription drugs

Indexed keywords

BUPRENORPHINE; FENTANYL; HYDROCODONE; HYDROMORPHONE; METHADONE; MORPHINE; NARCOTIC ANALGESIC AGENT; OXYCODONE;

ACCIDENTAL DEATH; ARTICLE; CLUSTER ANALYSIS; DRUG OVERDOSE; EMERGENCY HEALTH SERVICE; HUMAN; MORTALITY; PRESCRIPTION; PRIORITY JOURNAL; SPATIAL ANALYSIS; TREND STUDY; UNITED STATES; URBAN RURAL DIFFERENCE;

DRUG; NORTH CAROLINA; OPIATES; OPIODS; OVERDOSES; PRESCRIPTION DRUGS;

ANALGESICS, OPIOID; CLUSTER ANALYSIS; COMMERCE; DATA INTERPRETATION, STATISTICAL; DRUG OVERDOSE; HUMANS; LINEAR MODELS; NORTH CAROLINA; POPULATION DENSITY; PRESCRIPTION DRUGS; RURAL POPULATION; URBAN POPULATION;

EID: 84881667016     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2013.01.006     Document Type: Article

References (41)

1. Albert S., Brason F.W., Sanford C.K., Dasgupta N., Graham J., Lovette B. Project Lazarus: community-based overdose prevention in rural North Carolina. Pain Med. 2011, 12(Suppl. 2):S77-S85.
2. Anselin L. Local indicators of spatial association - LISA. Geogr. Anal. 1995, 27:93-115.
3. Blumenschein K., Fink J.L., Freeman P.R., James K., Kirsh K.L., Steinke D.T., Talbert J. Review of Prescription Drug Monitoring Programs in the United States 2010, Institute for Pharmaceutical Outcomes and Policy, Department of Pharmacy Practice and Science, College of Pharmacy, University of Kentucky.
4. Bohnert A.S., Valenstein M., Bair M.J., Ganoczy D., McCarthy J.F., Ilgen M.A., Blow F.C. Association between opioid prescribing patterns and opioid overdose-related deaths. JAMA 2011, 305:1315-1321.
5. Braden J.B., Russo J., Fan M.Y., Edlund M.J., Martin B.C., DeVries A., Sullivan M.D. Emergency department visits among recipients of chronic opioid therapy. Arch. Intern. Med. 2010, 170:1425.
6. Caravati E., Grey T., Nangle B., Rolfs R., Peterson-Porucznik C. Increase in poisoning deaths caused by non-illicit drugs-Utah, 1991-2003. MMWR 2005, 54:33-36.
7. CDC, 2011. CDC WONDER. (accessed 01.03.12). http://wonder.cdc.gov/.
8. Chou R., Fanciullo G.J., Fine P.G., Adler J.A., Ballantyne J.C., Davies P., Donovan M.I., Fishbain D.A., Foley K.M., Fudin J. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J. Pain 2009, 10:113-130. e122.
9. Dasgupta N., Kramer E.D., Zalman M.A., Carino S., Smith M.Y., Haddox J.D., Wright C. Association between non-medical and prescriptive usage of opioids. Drug Alcohol Depend. 2006, 82:135-142.
10. Dhalla I.A., Mamdani M.M., Sivilotti M.L.A., Kopp A., Qureshi O., Juurlink D.N. Prescribing of opioid analgesics and related mortality before and after the introduction of long-acting oxycodone. CMAJ 2009, 181:891-896.
11. Dunn K.M., Saunders K.W., Rutter C.M., Banta-Green C.J., Merrill J.O., Sullivan M.D., Weisner C.M., Silverberg M.J., Campbell C.I., Psaty B.M., Von Korff M. Opioid prescriptions for chronic pain and overdose: a cohort study. Ann. Intern. Med. 2010, 152:85-92.
12. Edlund M.J., Steffick D., Hudson T., Harris K.M., Sullivan M. Risk factors for clinically recognized opioid abuse and dependence among veterans using opioids for chronic non-cancer pain. Pain 2007, 129:355-362.
13. Gilson A.M., Ryan K.M., Joranson D.E., Dahl J.L. A reassessment of trends in the medical use and abuse of opioid analgesics and implications for diversion control: 1997-2002. J. Pain Symptom Manage. 2004, 28:176-188.
14. Hakenewerth A.M., Waller A.E., Ising A.I., Tintinalli J.E. North Carolina Disease Event Tracking and Epidemiologic Collection Tool (NC DETECT) and the National Hospital Ambulatory Medical Care Survey (NHAMCS): comparison of emergency department data. Acad. Emerg. Med. 2009, 16:261-269.
15. Hall A.J., Logan J.E., Toblin R.L., Kaplan J.A., Kraner J.C., Bixler D., Crosby A.E., Paulozzi L.J. Patterns of abuse among unintentional pharmaceutical overdose fatalities. JAMA 2008, 300:2613-2620.
16. Joranson D.E., Ryan K.M., Gilson A.M., Dahl J.L. Trends in medical use and abuse of opioid analgesics. JAMA 2000, 283:1710-1714.
17. Katz N., Panas L., Kim M., Audet A.D., Bilansky A., Eadie J., Kreiner P., Paillard F.C., Thomas C., Carrow G. Usefulness of prescription monitoring programs for surveillance-analysis of Schedule II opioid prescription data in Massachusetts, 1996-2006. Pharmacoepidemiol. Drug Saf. 2010, 19:115-123.
18. Kenan K., Mack K.A., Paulozzi L. Trends in prescriptions for oxycodone and other commonly used opioids in the United States, 2000-2010. Open Med. 2012, 6.
19. Kentucky PMP, 2011. Prescription Monitoring Program, KASPER (Kentucky All Schedule Prescription Electronic Reporting). (accessed 01.03.12). http://pmp.relayhealth.com/KY/.
20. Korff M.V., Saunders K., Thomas Ray G., Boudreau D., Campbell C., Merrill J., Sullivan M.D., Rutter C.M., Silverberg M.J., Banta-Green C., Weisner C. De facto long-term opioid therapy for noncancer pain. Clin. J. Pain 2008, 24:521-527.
21. Kulldorff M., Nagarwalla N. Spatial disease clusters: detection and inference. Stat. Med. 1995, 14:799-810.
22. Mahoney P. Statewide Initiative Aims to Curb Epidemic of Painkiller Overuse 2012, PRWEB.
23. McLellan A.T., Turner B.J. Chronic noncancer pain management and opioid overdose: time to change prescribing practices. Ann. Intern. Med. 2010, 152:123-124.
24. Morasco B.J., Duckart J.P., Carr T.P., Deyo R.A., Dobscha S.K. Clinical characteristics of veterans prescribed high doses of opioid medications for chronic non-cancer pain. Pain 2010, 151:625-632.
25. Novak S., Nemeth W.C., Lawson K.A. Trends in medical use and abuse of sustained-release opioid analgesics: a revisit. Pain Med. 2004, 5:59-65.
26. Paone D., Dowell D., Heller D. Preventing Misuse of Prescription Opioid Drugs 2011, The New York City Department of Health and Mental Hygiene, Long Island City, NY.
27. Paulozzi L., Annest J. Unintentional poisoning deaths-United States, 1999-2004. MMWR 2007, 56:93-96.
28. Paulozzi L.J., Stier D.D. Prescription drug laws, drug overdoses, and drug sales in New York and Pennsylvania. J. Public Health Policy 2010, 31:422-432.
29. Paulozzi L., Xi Y. Recent changes in drug poisoning mortality in the United States by urban-rural status and by drug type. Pharmacoepidemiol. Drug Saf. 2008, 17:997-1005.
30. Paulozzi L.J., Logan J.E., Hall A.J., McKinstry E., Kaplan J.A., Crosby A.E. A comparison of drug overdose deaths involving methadone and other opioid analgesics in West Virginia. Addiction 2009, 104:1541-1548.
31. Paulozzi L., Jones C., Mack K., Rudd R. Vital signs: overdoses of prescription opioid pain relievers-United States, 1999-2008. MMWR 2011, 60:1487-1492.
32. Paulozzi L.J., Kilbourne E.M., Desai H.A. Prescription drug monitoring programs and death rates from drug overdose. Pain Med. 2011, 12:747-754.
33. Sanford C.P. An unrelenting epidemic of deaths from prescription drugs in North Carolina. North Carolina Medical Board Forum 2008, 4-7.
34. Shah N.L.M. Unintentional deaths from drug poisoning by urbanization of area-New Mexico, 1994-2003. MMWR 2005, 54:870-873.
35. Sullivan M.D., Edlund M.J., Fan M.Y., DeVries A., Brennan Braden J., Martin B.C. Risks for possible and probable opioid misuse among recipients of chronic opioid therapy in commercial and medicaid insurance plans: The TROUP Study. Pain 2010, 150:332-339.
36. Utah Department of Health, 2009. Utah Clinical Guidelines on Prescribing Opioids for Treatment of Pain. Salt Lake City.
37. Washington Emergency Department Opioid Prescribing Guidelines, Viewed at the Consistent Care website on 8/19/11 at: http://washingtonacep.org/Postings/edopioidabuseguidelinesfinal.pdf.
38. White A., Birnbaum H., Schiller M., Tang J., Katz N. Analytic models to identify patients at risk for prescription opioid abuse. Am. J. Manage. Care 2009, 15:897.
39. Wisniewski A.M. Epidemiologic association between opioid prescribing, non-medical use, and emergency department visits. J. Addict. Dis. 2008, 27.
40. Wisniewski A.M., Purdy C.H., Blondell R.D. The epidemiologic association between opioid prescribing, non-medical use, and emergency department visits. J. Addict. Dis. 2008, 27:1-11.
41. Wunsch M.J., Nakamoto K., Behonick G., Massello W. Opioid deaths in rural Virginia: a description of the high prevalence of accidental fatalities involving prescribed medications. Am. J. Addict. 2009, 18:5-14.